PUBLISHER: Grand View Research | PRODUCT CODE: 1553524
PUBLISHER: Grand View Research | PRODUCT CODE: 1553524
The global retinal surgery devices market size is expected to reach USD 4.22 billion in 2030 and is projected to grow at a CAGR of 5.5% from 2024 to 2030. The unprecedented growth is presumed to be a consequence of the growing prevalence of retinal eye disorders such as retinal detachment, macular degeneration, amblyopia, and others. Rising patient preference for minimally invasive surgeries is believed to be one of the major growth of contributory factors. The increasing demand is predicted to be a result of associated benefits such as improved cost-efficiency, safety, rapid recovery, efficacy, and reduced hospital stay. Other advantages include fewer incision wounds and reduced postsurgical complications that lead to higher patient satisfaction.
The market is also driven by technological upgradations that are responsible for the heightened inclination of physicians, thereby, widening the scope for greater adoption of retinal surgery devices in the future. The technologically advanced devices are equipped with fundus imaging units, micro-incision technology, endoillumination systems. These advancements are primarily witnessed in surgical instrumentation to facilitate easy & safe operative procedures. For instance, the launch of VersaVIT 2.0 vitrectomy machine is equipped with an LED illumination system, 3 vitrectomy packs, and adjustable chandelier fiber. Similarly, 23-Gauge fragmentation needle eliminates the need to enlarge sclerotomy and achieve enhanced visualization, intraoperative efficiency, and control.